Beta Bionics partners with Senseonics to integrate iLet bionic pancreas with Eversense 365 CGM
BBNX•
BBNX•The companies also committed to integrate Beta Bionics’ mint automated insulin delivery system with Eversense 365 at a later date.
Beta Bionics expects iLet to support the widest range of CGM options among automated insulin delivery systems once the integration launches.
Beta Bionics entered a partnership with Senseonics to integrate the iLet Bionic Pancreas with the Eversense 365 continuous glucose monitor.
Commercial launch of the integrated iLet-Eversense 365 system is expected in Q4 2026.